The fusion antibodies by themselves could stimulate T cell proliferation, survival, and some effector functions, e.g., cytokine production, and they showed enhancement trends for other effector T cell activities like granzyme B production and the lysis of ovarian cancer cells that were used as a target cancer model. Here, GZMB is linked to ovarian cancer.